Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amelioration of small bowel injury by switching from nonselective nonsteroidal anti-inflammatory drugs to celecoxib in rheumatoid arthritis patients: a pilot study.
Inoue T, Iijima H, Arimitsu J, Hagihara K, Kawai S, Shiraishi E, Hiyama S, Mukai A, Shinzaki S, Nishida T, Ogata A, Tsujii M, Takehara T. Inoue T, et al. Among authors: hiyama s. Digestion. 2014;89(2):124-32. doi: 10.1159/000357229. Epub 2014 Feb 7. Digestion. 2014. PMID: 24526219 Clinical Trial.
Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease.
Inoue T, Iijima H, Tajiri M, Shinzaki S, Shiraishi E, Hiyama S, Mukai A, Nakajima S, Iwatani H, Nishida T, Mizushima T, Yasui T, Isaka Y, Kanto T, Tsujii M, Miyoshi E, Wada Y, Takehara T. Inoue T, et al. Among authors: hiyama s. Inflamm Bowel Dis. 2012 Sep;18(9):1723-34. doi: 10.1002/ibd.22876. Epub 2012 Jan 12. Inflamm Bowel Dis. 2012. PMID: 22241690
Regulation of anergy-related ubiquitin E3 ligase, GRAIL, in murine models of colitis and patients with Crohn's disease.
Mukai A, Iijima H, Hiyama S, Fujii H, Shinzaki S, Inoue T, Shiraishi E, Kawai S, Araki M, Hayashi Y, Kondo J, Mizushima T, Kanto T, Egawa S, Nishida T, Tsujii M, Takehara T. Mukai A, et al. Among authors: hiyama s. J Gastroenterol. 2014 Dec;49(12):1524-35. doi: 10.1007/s00535-013-0923-x. Epub 2013 Dec 20. J Gastroenterol. 2014. PMID: 24356810
5‑FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53‑mutated colon cancer cells.
Akasaka T, Tsujii M, Kondo J, Hayashi Y, Ying J, Lu Y, Kato M, Yamada T, Yamamoto S, Inoue T, Tsujii Y, Maekawa A, Fujinaga T, Shiraishi E, Hiyama S, Inoue T, Shinzaki S, Watabe K, Nishida T, Iijima H, Takehara T. Akasaka T, et al. Among authors: hiyama s. Int J Oncol. 2015 Jan;46(1):63-70. doi: 10.3892/ijo.2014.2693. Epub 2014 Oct 6. Int J Oncol. 2015. PMID: 25310623
The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
Ying J, Tsujii M, Kondo J, Hayashi Y, Kato M, Akasaka T, Inoue T, Shiraishi E, Inoue T, Hiyama S, Tsujii Y, Maekawa A, Kawai S, Fujinaga T, Araki M, Shinzaki S, Watabe K, Nishida T, Iijima H, Takehara T. Ying J, et al. Among authors: hiyama s. Int J Oncol. 2015 Apr;46(4):1551-9. doi: 10.3892/ijo.2015.2851. Epub 2015 Jan 26. Int J Oncol. 2015. PMID: 25625841
106 results